Rocket Pharmaceuticals completes $180 million priority review voucher sale

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. SPY
2. USO
3. IONQ
4. IONS
5. AAPL
6. ACN
7. AZN
8. ROIV
9. HOOD
10. QCOM

Go back to Rocket Pharmaceuticals completes $180 million priority review voucher sale
(NASDAQ: RCKT) Delayed: 3.73 -0.13 (3.37%)
Previous Close $3.86    52 Week High $ 
Open $3.78    52 Week Low $ 
Day High $3.78    P/E N/A 
Day Low $3.68    EPS $ 
Volume 549,356